DadFinStart your free week
DadFin › Stocks › Technology › ACLS

Axcelis Technologies, Inc. (ACLS) stock score

Technology · Semiconductor Equipment & Materials · United States

$134.71 ▲ +0.92% today

40.5
Dad Score, out of 100
middling

Axcelis Technologies, Inc. (ACLS) is a Semiconductor Equipment & Materials company in the Technology sector, listed in the United States. On DadFin's weekly run it scores 40.5 out of 100 on the Dad Score, a middling reading that places the business ahead of 40% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Technology it ranks #466 of 780. Its strongest axis is price action; its weakest are quality and growth.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Average
Quality
Below average
Growth
Weak
Price action
Above average
Risk
Average
Conviction
Average
Liquidity
Average
Macro
Below average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)49.4×
P/E (forward)28.1×
Dividend yield0.00%
Return on capital12.3%
Operating margin9.4%
Revenue growth (YoY)-17.6%
FCF yield2.4%
Net debt / EBITDA-3.34×
Piotroski F-Score4 / 9
52-week change+68.5%
Market cap$4.6B
Next earningsNov 3, 2026

What subscribers see on ACLS

Start your free weekSubscriber? Open the full research →

Semiconductor Equipment & Materials peers

StockCompanyDad ScoreBandMarket cap
ASMLASML Holding N.V.78.1good$717.2B
LRCXLam Research Corporation86.2strong$434.9B
AMATApplied Materials, Inc.72.4good$428.6B
KLACKLA Corporation72.9good$270.0B
TERTeradyne, Inc.50.0middling$70.2B
QQnity Electronics, Inc.71.3good$27.5B
ENTGEntegris, Inc.44.8middling$25.4B
ONTOOnto Innovation Inc.52.3middling$20.0B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.